metabolic
Chronic Inflammation and GLP-1 Medications
Chronic low-grade inflammation drives metabolic disease and accelerates aging. GLP-1 medications have potent anti-inflammatory effects.
30-50%
CRP reduction
Significant
Cytokine reduction
3-6 months
Timeline
Anti-Inflammatory Benefits
GLP-1 medications reduce systemic inflammation through multiple pathways. They lower C-reactive protein (CRP) and other inflammatory markers. They reduce inflammatory cytokine production in adipose tissue. They improve gut barrier function, reducing endotoxin leakage. They modulate immune cell function. These anti-inflammatory effects contribute to cardiovascular protection and metabolic improvement. Some research suggests benefits for inflammatory conditions beyond metabolic disease.
Measuring Improvement
Baseline inflammatory markers (CRP, ESR) establish starting point. Improvements seen within 3-6 months. Weight loss itself reduces inflammation. GLP-1s provide additional anti-inflammatory benefits beyond weight loss.
Medications commonly used
Find providers who understand chronic inflammation
Compare GLP-1 providers by clinical oversight, medication options, pricing, and local availability.
Related conditions